Skip to main content
. 2013 Jun 14;62(7):2539–2544. doi: 10.2337/db12-1773

FIG. 2.

FIG. 2.

Plasma concentrations of insulin GLA and its metabolites M1 and M2 at baseline and at 36 weeks of insulin GLA therapy determined by LCMS. Results are shown as median with interquartile ranges. The broken line shows the detection limit for all three substances (0.20 ng/mL).